Walgreens Specialty Pharmacy to dispense Ibrance for those requiring access to advanced, metastatic breast cancer therapy

New Drug Available to Treat ER+/HER2- Advanced, Metastatic Breast Cancer in Postmenopausal Women

DEERFIELD, Ill., 2015-2-20 — /EPR Retail News/ — Walgreens today announced that Ibrance® (palbociclib) is immediately available through Walgreens Specialty Pharmacy for those requiring access to advanced, metastatic breast cancer therapy. Walgreens Specialty Pharmacy was selected by Pfizer as one of a group of pharmacies to dispense Ibrance, for use, in combination with letrozole, as initial endocrine-based therapy for postmenopausal women with ER+/HER2- advanced breast cancer. Walgreens Specialty Pharmacy also has access to letrozole, the required accompaniment drug.

“Through our integrated clinical and specialty distribution assets, we deliver comprehensive and collaborative patient care for those within the breast cancer community and are pleased to be able to better serve patients requiring this anti-cancer medication,” said Mike Ellis, Walgreens corporate vice president, specialty and infusion pharmacy.

Working collaboratively with oncology providers, Walgreens Specialty Pharmacy delivers comprehensive patient care for those managing cancer therapies. Patients benefit from Walgreens access to limited distribution drugs, as well as a number of support services. These include help verifying insurance and identifying financial assistance options and supportive nutrition care through Walgreens infusion services capabilities.

Ibrance is available at select Walgreens specialty, community and health system pharmacies.

For more information, visit www.walgreens.com/pharmacy/specialtypharmacy.jsp. For more information about Ibrance, visit www.ibrance.com.

About Walgreens
Walgreens (www.walgreens.com), the nation’s largest drugstore chain, constitutes the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 8 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,229 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens digital business includes Walgreens.com, drugstore.com, Beauty.com, SkinStore.com and VisionDirect.com. Walgreens also manages more than 400 Healthcare Clinic and provider practice locations around the country.


Markeisha Marshall, (847) 315-2923